December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology
Apr 13, 2024, 09:52

Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology

Matt Campbell, Genitorurinary medical oncologist at UT MD Anderson Cancer center, shared a post on X:

HOT OFF THE PRESS: Happy to share the results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology from MD Anderson Cancer center.

Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology

Source: Matt Campbell/X